Последние исследования


EudraCT Number: 2006-004222-93 Sponsor Protocol Number: GPE 02 Start Date: 2006-11-28
Sponsor Name: Curalogic A/S
Full Title: Assessment of the Maximal Tolerated Dose of a Microencapsulated Grass (Phleum pratense) Pollen Extract (MGPE) in Subjects with Grass Pollen Allergy in a Randomized, Double-Blind, Placebo-Controlled...
Medical condition: Treatment of seasonal allergic rhinitis to grass pollen.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: (No results available)

EudraCT Number: 2006-004775-35 Sponsor Protocol Number: ESA-2 Start Date: 2006-11-28
Sponsor Name: Barts and the London NHS Trust
Full Title: The Effect of Treating Patients with Anaemia in Diabetic Nephropathy to different target haemoglobin levels with Epoetin Beta
Medical condition: Anaemia in Diabetic Nephropathy
Disease: Version SOC Term Classification Code Term Level
8.1 10002071 Anaemia NOS LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2006-003163-31 Sponsor Protocol Number: AI424-328 Start Date: 2006-11-28
Sponsor Name: Bristol-Myers Squibb International Corporation
Full Title: Open-Label, Multiple-Dose, Drug Interaction Study to Assess the Effect of Famotidine with or without Tenofovir on the Pharmacokinetics of Atazanavir when given with Ritonavir in HIV-Infected Subjec...
Medical condition: HIV infected Subjects
Disease: Version SOC Term Classification Code Term Level
8.1 10020161 HIV infection LLT
Population Age: Adults Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2006-005609-76 Sponsor Protocol Number: SSAT 018 Start Date: 2006-11-28
Sponsor Name: St Stephens Aids Trust
Full Title: EFFECT OF DIFFERENT MEALS ON THE PHARMACOKINETIC PROFILE OF SAQUINAVIR AT STEADY STATE IN HIV-INFECTED PATIENTS TREATED WITH SAQUINAVIR/RITONAVIR 1000/100 mg BID.
Medical condition: HIV
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2006-004076-13 Sponsor Protocol Number: 5 Start Date: 2006-11-28
Sponsor Name: Huvud- hals- lung- och hudcancer, Tema Cancer Karolinska Universitetssjukhuset
Full Title: Secar I Part I: A study of MTD of Sodium selenite in patients with advanced carcinoma. A phase I study. Amendment 5: continuous treatment
Medical condition: Patients with stage III or IV cancer in whom first and second line treatment have been given but who have tumours that are still progressing, giving symptomes. The patients must be in a fairly good...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Restarted)
Trial results: (No results available)

EudraCT Number: 2006-005239-32 Sponsor Protocol Number: PDE5 Start Date: 2006-11-28
Sponsor Name: Medical Sciences, Akademiska sjukhuset
Full Title: Fosfodiesterashämmares akuta hemodynamiska effekter vid pulmonell hypertension och utvärdering av kväveoxid mätningar som icke-invasiv diagnostisk metod
Medical condition:  Pulmonell hypertension med kvarstående förhöjt medeltryck i arteria pulmonalis överstigande 25 mmHg i vila eller >30 mmHg under ansträngning vid hjärtkateterisering definierad av National Institu...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Ongoing)
Trial results: (No results available)
EudraCT Number: 2007-006754-26 Sponsor Protocol Number: PLA/01/06 Start Date: 2006-11-28
Sponsor Name: MASTELLI SRL
Full Title: DIABETIC FOOT ULCERS AND POLYDEOXYRIBONUCLEOTIDE (PLACENTEX INTEGRO MASTELLI) AS A TREATMENT FOR WOUND HEALING
Medical condition: Diabetic foot ulcer
Disease: Version SOC Term Classification Code Term Level
9.1 10056340 Diabetic ulcer LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed) SI (Completed)
Trial results: (No results available)

EudraCT Number: 2006-003876-37 Sponsor Protocol Number: CS866CM-B-E301 Start Date: 2006-11-28
Sponsor Name: DAIICHI SANKYO EUROPE GmbH
Full Title: Efficacy and Safety of Hydrochlorothiazide Used as Add-on Therapy in Moderately to Severely Hypertensive Patients not Adequately Controlled by Olmesartan Medoxomil 40 mg Monotherapy
Medical condition: Essential hypertension
Disease: Version SOC Term Classification Code Term Level
8.1 10015488 Essential hypertension LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) CZ (Completed) FR (Ongoing) ES (Completed)
Trial results: View results
EudraCT Number: 2006-002565-39 Sponsor Protocol Number: 2006015 Start Date: 2006-11-27
Sponsor Name: South Tees Acute Hospitals NHS Trust
Full Title: Effects of the Modification of the Daily Flow Rate with a Constant Daily Dose on Patient's Reported Analgesia in Intathecal Therapy
Medical condition: Chronic Pain.
Disease: Version SOC Term Classification Code Term Level
8.1 10049475 Chronic pain LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2006-004979-35 Sponsor Protocol Number: 05-FOR-01 SE Start Date: 2006-11-27
Sponsor Name: Andi - Ventis
Full Title: A RANDOMISED, FOUR WAY CROSS-OVER STUDY TO ASSESS BRONCHODILATION, SAFETY AND TOLERABILITY OF NEW GENERIC DRY POWDER FORMOTEROL FORMULATIONS GIVEN AS CUMULATIVE DOSES FROM A NOVEL DRY POWDER INHALE...
Medical condition: reversible mild asthma
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: HU (Completed)
Trial results: (No results available)
Подписаться